cagrisema phase 3 results 2024 2025 semaglutide cagrilintide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study REDEFINE 2 CagriSema Trial |

Practical takeaway: If you know youre starting a drinking session already dehydrated after a workout, a hot day, or being sick its reasonable to assume your actual BAC may run a bit higher than a standard calculator estimate suggests, and to plan your drinking and transportation accordingly

BPC-157, TB-500, and IGF-1 LR3 have no completed human trials at all

Adding multiple additional compounds creates complexity that makes it impossible to identify what is working (or causing problems)

If their concentration is 5,000 mcg/mL, 10 units is 500 mcg

The volume math is correct but the bac water is bad

Most patients experience identical outcomes on either formulation